City Therapeutics logo

City Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$135M


City Therapeutics is a biopharmaceutical company focused on developing RNA interference-based medicines using engineered small interfering RNAs to target a broad range of diseases.

Total Funding

$135M

Headquarters

Cambridge, USA

Founded

N/A

Website

Focus Areas

Biopharmaceutical
RNAi
siRNA
Therapeutics
Drug Development
Engineering

Investors

ARCH Venture Partners logo
Fidelity Management & Research Company logo
Invus logo
Rock Springs Capital logo
Regeneron Ventures logo
Slate Path Capital logo
AN Ventures logo